Showing results (61-70 of 72) with videos related to
Sort By:
Pageof 8
Plant Signaling & Behavior|August 4, 2009
Two different signaling pathways for thaxtomin A-induced cell death in Arabidopsis and tobacco BY2Patrice Meimoun, Daniel Tran, Mohamed Baz, et al.Journal of Animal Science|August 13, 2020
The combination of nutraceuticals and functional feeds as additives modulates gut microbiota and blood markers associated with immune response and health in weanling pigletsLuca Lo Verso, Guylaine Talbot, Bruno Morissette, et al.Plos One|August 25, 2015
Infection Efficiency of Four Phytophthora infestans Clonal Lineages and DNA-Based Quantification of SporangiaMamadou Lamine Fall, David Mathieu Tremblay, Mélanie Gobeil-Richard, et al.Microbiology Spectrum|August 28, 2024
The role of exopolysaccharides Psl and Pel in resistance of <i>Pseudomonas aeruginosa</i> to the oxidative stressors sodium hypochlorite and hydrogen peroxideWaleska S da Cruz Nizer, Kira N Allison, Madison E Adams, et al.Bioorganic & Medicinal Chemistry Letters|April 6, 2010
Identification of a novel series of potent RON receptor tyrosine kinase inhibitorsStéphane Raeppel, Frédéric Gaudette, Michael Mannion, et al.Cancer Research|August 3, 2002
Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumorsMarielle Fournel, Marie-Claude Trachy-Bourget, P Theresa Yan, et al.Bioorganic & Medicinal Chemistry Letters|November 10, 2009
N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinasesOscar Saavedra, Stephen Claridge, Lijie Zhan, et al.Journal of Medicinal Chemistry|February 21, 2003
Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitorsGiliane Bouchain, Silvana Leit, Sylvie Frechette, et al.Bioorganic & Medicinal Chemistry Letters|December 20, 2003
(2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitorsArkadii Vaisburg, Naomy Bernstein, Sylvie Frechette, et al.Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.Pageof 8